English: List of Participants Stakeholder Workshop on a National Buprenorphine Program Health Canada November 18, 2004 Participants List Mr. Richard Arlen Product Manager  Schering Canada Ms. Carole Bouchard A/Director General Drug Strategy and Controlled Substances Programme  Health Canada Dr. Suzanne Brissette  Canadian Society of Addiction Medicine Ms. Connie Coté Director of Professional Affairs  The Federation of Medical Regulatory Authorities of Canada Mr. Greg Eberhart Registrar  Alberta College of Pharmacists Dr. Doug Gourlay  Centre for Addiction and Mental Health Mr. Wade Hillier Manager, Government Programs College of Physicians and Surgeons of Ontario Dr. Meldon Kahan  Centre for Addiction and Mental Health Dr. Patrice Larose, VP, Regulatory Affairs, Drug Safety and Medical Services Schering Canada Dr. Lowell Loewen College of Physicians and Surgeons of Saskatchewan Dr. David Marsh Canadian Society of Addiction Medicine Dr. Siddika Mithani Director Therapeutic Products Directorate Health Canada Mme. Josée Morin Inspecteure-conseillère professionnelle  Adjointe à la directrice des services professionnels  Ordre des pharmaciens du Québec Dr. Brenda Osmond  Deputy Registrar  College of Pharmacists of British Columbia Dr. Cathy Petersen  Manager  Central Nervous System Division  Health Canada Dr. Robert Peterson  Director General  Therapeutic Products Directorate  Health Canada Mr. Ken Potvin  Executive Director  National Association of Pharmacy Regulatory Authorities Dr. Marcel Provost  Collège des médecins du Québec Ms. Karen Reynolds  Associate Director  Therapeutic Products Directorate  Health Canada Ms. Theresa Schopf  A/Head, Policy Section  Office of Controlled Substances  Health Canada Mr. Randy Steffan  Federal Health Affairs Manager  Schering Canada Mr. Greg Ujiye  Manager, Pharmacy Practice  Ontario College of Pharmacists Dr. Lloyd Westby  Physician Ms. Stephanie Yung-Hing  Policy & Strategic Planning Directorate  Health Canada Facilitators Ms. Kathleen Connelly  Intersol Group Ltd.
French: Participants Atelier d'intervenants au sujet d'un programme national sur la buprénorphine Santé Canada Le 18 novembre 2004 Participants Mr. Richard Arlen Product Manager  Schering Canada Ms. Carole Bouchard A/Director General Drug Strategy and Controlled Substances Programme  Health Canada Dr. Suzanne Brissette  Canadian Society of Addiction Medicine Ms. Connie Coté Director of Professional Affairs  The Federation of Medical Regulatory Authorities of Canada Mr. Greg Eberhart Registrar  Alberta College of Pharmacists Dr. Doug Gourlay  Centre for Addiction and Mental Health Mr. Wade Hillier Manager, Government Programs College of Physicians and Surgeons of Ontario Dr. Meldon Kahan  Centre for Addiction and Mental Health Dr. Patrice Larose, VP, Regulatory Affairs, Drug Safety and Medical Services Schering Canada Dr. Lowell Loewen College of Physicians and Surgeons of Saskatchewan Dr. David Marsh Canadian Society of Addiction Medicine Dr. Siddika Mithani Director Therapeutic Products Directorate Health Canada Mme Josée Morin Inspecteure-conseillère professionnelle  Adjointe à la directrice des services professionnels  Ordre des pharmaciens du Québec Dr. Brenda Osmond  Deputy Registrar  College of Pharmacists of British Columbia Dr. Cathy Petersen  Manager  Central Nervous System Division  Health Canada Dr. Robert Peterson  Director General  Therapeutic Products Directorate  Health Canada Mr. Ken Potvin  Executive Director  National Association of Pharmacy Regulatory Authorities Dr. Marcel Provost  Collège des médecins du Québec Ms. Karen Reynolds  Associate Director  Therapeutic Products Directorate Health Canada Ms. Theresa Schopf  A/Head, Policy Section  Office of Controlled Substances  Health Canada Mr. Randy Steffan  Federal Health Affairs Manager  Schering Canada Mr. Greg Ujiye  Manager, Pharmacy Practice  Ontario College of Pharmacists Dr. Lloyd Westby  Physician Ms. Stephanie Yung-Hing  Policy & Strategic Planning Directorate  Health Canada Secretariat Ms. Kathleen Connelly  Intersol Group Ltd.